Results 251 to 260 of about 174,736 (301)

Global burden of gout in age groups 10 to 54 years from 1990 to 2021: Trend of the global burden of disease study. [PDF]

Medicine (Baltimore)
Shi K, Guo Y, You T.
europepmc   +1 more source

Frailty as a Key Determinant of Cardiovascular Risk and Mortality in Preserved Ratio Impaired Spirometry: A Nationally Representative Study

The Clinical Respiratory Journal, Volume 20, Issue 1, January 2026.
In adults with preserved ratio impaired spirometry (PRISm), frailty was common and strongly associated with increased cardiovascular events and all‐cause mortality. Frailty significantly improved risk stratification beyond traditional clinical factors. A frailty‐based nomogram demonstrated good discrimination and calibration, highlighting frailty as a ...
Yue Ren, Yixing Wu, Weiping Hu, Li Liu, Hui Cai, Jing Zhang   +5 more
wiley   +1 more source

Partial non‐adherence to antidiabetic therapy undermines diabetes management and correlates with treatment complexity: A cross‐sectional study using blood plasma analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 186-196, January 2026.
Abstract Aims To evaluate medication adherence in patients with type 2 diabetes (T2D) using plasma drug measurements and assess the clinical impact of partial non‐adherence on glycemic control and complications. Materials and Methods This cross‐sectional study included 641 T2D outpatients attending routine follow‐up visits.
Vojtěch Škop, Ivana Laňková, Simona Antalová, Iva Míšková, Kateřina Malá‐Ládová, Josef Malý, Terezie Pelikánová, Jiří Hricko, Tomáš Čajka, Martin Haluzík   +9 more
wiley   +1 more source

The disease burden of gout in Asian countries and regions from 1990 to 2021, risk factors and forecast analysis: A systematic study of Asian disease burden in 2021

Fuyu Yang, Runze Chen, Jun Xiong, Wenzhen Wang, Peng Yu, Huilin Wang   +5 more
openalex   +1 more source

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 728-740, January 2026.
Abstract Aims This study aimed to evaluate the efficacy and safety of triple therapy with lobeglitazone 0.5 mg as an add‐on treatment compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin.
Da Hea Seo, Kyung Wan Min, Ho Sang Sohn, Sang Yong Kim, In‐Kyung Jeong, Cheol‐Young Park, Kun‐Ho Yoon, So Hun Kim, Bong‐Soo Cha   +8 more
wiley   +1 more source

Risk factors for early-onset hyperuricemia and gout following laparoscopic sleeve gastrectomy: a retrospective study. [PDF]

BMC Surg
Fu C, Han Y, Chen J, Chen J, Chen Y, Liang X, Sun L.   +6 more
europepmc   +1 more source

Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale

Geriatrics &Gerontology International, Volume 26, Issue 1, January 2026.
ABSTRACT The increased anticholinergic burden caused by medications in older adults is one of the adverse drug reactions of particular concern, as it can exacerbate the onset of geriatric syndromes or induce cognitive dysfunction, and is also related to the issue of polypharmacy.
Masaki Mogi, Shuang Liu, Yasuyuki Suzuki, Yuuka Shibata, Shizuo Yamada   +4 more
wiley   +1 more source

Gout as a Distal Extremity Hypothermia: A Triad Therapeutic Protocol

Choi, Il Woong
openalex   +1 more source

The Immunological Consequences of Clonal Hematopoiesis in Heart Failure

Immunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Inflammation is increasingly recognized as a central driver of heart failure (HF), particularly in older adults, yet the underlying immune mechanisms remain diverse and incompletely understood. Clonal hematopoiesis (CH), defined by the expansion of somatically mutated hematopoietic clones, has emerged as a risk factor for the development of ...
Megan A. Evans, Kenneth Walsh
wiley   +1 more source

Metabolic dysfunction-associated fatty liver disease and the risk of gout: a UK Biobank prospective cohort study. [PDF]

Eur J Med Res
Liu X, Wang Y, Song H, Tian ZB, Wang YG, Yu Q, Li C, Niu Q, Zhu XJ, Chen Y.   +9 more
europepmc   +1 more source